Horizon Pharma plc·4

Mar 24, 6:52 PM ET

Horizon Pharma plc 4

4 · Horizon Pharma plc · Filed Mar 24, 2016

Insider Transaction Report

Form 4
Period: 2016-03-23
Kelly David George
EVP & Corporate Secretary
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2016-03-23+19,25019,250 total(indirect: By Trust)
  • Exercise/Conversion

    Restricted Stock Units

    2016-03-2319,25057,750 total
    Ordinary Shares (19,250 underlying)
Holdings
  • Ordinary Shares

    125,888
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]On March 23, 2015, the reporting person was granted 77,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION